-Reuters
Goldman Sachs Maintains Neutral on Edwards Lifesciences, Lowers Price Target to $73
Goldman Sachs analyst Amit Hazan maintains Edwards Lifesciences (NYSE:EW) with a Neutral and lowers the price target from $97 to $73.
Related Posts
Goldman Sachs Downgrades Gritstone Bio to Sell, Announces $2 Price Target
Goldman Sachs analyst Corinne Jenkins downgrades Gritstone Bio (NASDAQ:GRTS) from Neutral to Sell and announces $2 price target.
Wells Fargo Initiates Coverage On Ping Identity Holding with Overweight Rating, Announces Price Target of $32
Wells Fargo analyst Andrew Nowinski initiates coverage on Ping Identity Holding (NYSE:PING) with a Overweight rating and announces Price Target of $32.
